Citations for
1EGR2, PMP22, SOX10, TEAD1
Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
Lopez-Anido C, Poitelon Y, Gopinath C, Moran JJ, Ma KH, Law WD, Antonellis A, Feltri ML, Svaren J.
Hum Mol Genet 25(14):3055-3069. Epub 2016 Jun 10. 2016
2CMT1A, PMP22
Mechanism, Prevalence, and More Severe Neuropathy Phenotype of the Charcot-Marie-Tooth Type 1A Triplication.
Liu P, Gelowani V, Zhang F, Drory VE, Ben-Shachar S, Roney E, Medeiros AC, Moore RJ, Divincenzo C, Burnette WB, Higgins JJ, Li J, Orr-Urtreger A, Lupski JR.
Am J Hum Genet 94(3):462-9. doi: 10.1016/j.ajhg.2014.01.017. Epub 2014 Feb 13. 2014
3CDRT4, CMT1A, HNPP, PMP22, TEKT3
Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22.
Jones EA, Brewer MH, Srinivasan R, Krueger C, Sun G, Charney KN, Keles S, Antonellis A, Svaren J.
Hum Mol Genet 21(7):1581-91. doi: 10.1093/hmg/ddr595. Epub 2011 Dec 15. 2012
4HNPP, PMP22
Variable phenotypes are associated with PMP22 missense mutations.
Russo M, Laurá M, Polke JM, Davis MB, Blake J, Brandner S, Hughes RA, Houlden H, Bennett DL, Lunn MP, Reilly MM.
Neuromuscul Disord 21(2):106-14. Epub 2010 Dec 30. 2011
5PMP22
Regulation of the PMP22 gene through an intronic enhancer.
Jones EA, Lopez-Anido C, Srinivasan R, Krueger C, Chang LW, Nagarajan R, Svaren J.
J Neurosci. 31(11):4242-50. 2011
6CMT1A, HNPP, PMP22
Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability.
Zhang F, Seeman P, Liu P, Weterman MA, Gonzaga-Jauregui C, Towne CF, Batish SD, De Vriendt E, De Jonghe P, Rautenstrauss B, Krause KH, Khajavi M, Posadka J, Vandenberghe A, Palau F, Van Maldergem L, Baas F, Timmerman V, Lupski JR.
Am J Hum Genet 86(6):892-903. Epub 2010 May 20.PMID: 20493460 [ 2010
7CANX, PMP22
Calnexin deficiency leads to dysmyelination.
Kraus A, Groenendyk J, Bedard K, Baldwin TA, Krause KH, Dubois-Dauphin M, Dyck J, Rosenbaum EE, Korngut L, Colley NJ, Gosgnach S, Zochodne D, Todd K, Agellon LB, Michalak M.
J Biol Chem 285(24):18928-38. Epub 2010 Apr 16. 2010
8DSS1, PMP22
Compound heterozygous PMP22 deletion mutations causing severe Charcot-Marie-Tooth disease type 1.
Abe A, Nakamura K, Kato M, Numakura C, Honma T, Seiwa C, Shirahata E, Itoh A, Kishikawa Y, Hayasaka K.
J Hum Genet 55(11):771-3. Epub 2010 Aug 26. 2010
9DSS1, PMP22
Compound heterozygous deletions of PMP22 causing severe Charcot-Marie-Tooth disease of the Dejerine-Sottas disease phenotype.
Al-Thihli K, Rudkin T, Carson N, Poulin C, Melançon S, Der Kaloustian VM.
Am J Med Genet A 146A(18):2412-6. 2008
10HNPP, PMP22
Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies.
Li J, Ghandour K, Radovanovic D, Shy RR, Krajewski KM, Shy ME, Nicholson GA.
Arch Neurol 64(7):974-8. Erratum in: Arch Neurol. 2007 Oct;64(10):1547. Radovanovic, Danuijola [corrected to Radovanovic, Danijela]. 2007
11PMP22
Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression.
Fortun J, Go JC, Li J, Amici SA, Dunn WA Jr, Notterpek L.
Neurobiol Dis 22(1):153-64. Epub 2005 Dec 2. 2006
12LITAF, PMP22, CMT1A, CMT1C, CMT1E
Early onset neuropathy in a compound form of Charcot-Marie-Tooth disease.
Meggouh F, de Visser M, Arts WF, De Coo RI, van Schaik IN, Baas F.
Ann Neurol 57(4):589-91. 2005
13DSS1,PMP22
Dejerine-Sottas syndrome and vestibular loss due to a point mutation in the PMP22 gene.
Jen J, Baloh RH, Ishiyama A, Baloh RW.
J Neurol Sci 237(1-2):21-4. 2005
14PMP22
Recessive, but not dominant, mutations in peripheral myelin protein 22 gene show unique patterns of aggregation and intracellular trafficking.
Liu N, Yamauchi J, Shooter EM.
Neurobiol Dis 17(2):300-9. 2004
15PMP22, AIDP
Family with inflammatory demyelinating polyneuropathy and the HNPP 17p12 deletion.
Korn-Lubetzki I, Argov Z, Raas-Rothschild A, Wirguin I, Steiner I.
Am J Med Genet 113(3):275-8. 2002
16PMP22
Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for "gain-of-function" ER diseases.
Dickson KM, Bergeron JJ, Shames I, Colby J, Nguyen DT, Chevet E, Thomas DY, Snipes GJ.
Proc Natl Acad Sci U S A. 99(15):9852-7. 2002
17CDRT@, CDRT1, CDRT11, CDRT12, CDRT13, CDRT14, CDRT15, CDRT2, CDRT3, CDRT4, CDRT5, CDRT6, CDRT7, CDRT8, CDRT9, CDRT10, CMT1AREPT, HS3ST3A1, HS3ST3B1, PMP22, TEKT3, CDRT15P
The 1.4-Mb CMT1A Duplication/HNPP Deletion Genomic Region Reveals Unique Genome Architectural Features and Provides Insights into the Recent Evolution of New Genes.
Inoue K, Dewar K, Katsanis N, Reiter LT, Lander ES, Devon KL, Wyman DW, Lupski JR, Birren B.
Genome Res 11(6):1018-33. 2001
18PMP22
Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia.
Notterpek L, Roux KJ, Amici SA, Yazdanpour A, Rahner C, Fletcher BS.
Proc Natl Acad Sci U S A 98(25):14404-9. 2001
19PMP22
Identification of a positive regulatory element in the myelin-specific promoter of the PMP22 gene.
Hai M, Bidichandani SI, Patel PI.
J Neurosci Res 65(6):508-19. 2001
20HNPP, PMP22
Hereditary neuropathy with liability to pressure palsies: two cases with a reciprocal translocation t(16;17)(q12;11.2) interrupting the PMP22 gene.
Nadal M, Valiente A, Domenech A, Pritchard M, Estivill X, Ramos-Arroyo MA.
J Med Genet 37(5):396-8. No abstract available. 2000
21PMP22
Molecular dissection of the Schwann cell specific promoter of the PMP22 gene.
Saberan-Djoneidi D, Sanguedolce V, Assouline Z, Levy N, Passage E, Fontes M.
Gene 248(1-2):223-31. 2000
22PMP22
Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22.
Niemann S, Sereda MW, Suter U, Griffiths IR, Nave KA.
J Neurosci. 20(11):4120-8. 2000
23PMP22
Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy
Isaacs AM, Davies KE, Hunter AJ, Nolan PM, Vizor L, Peters J, Gale DG, Kelsell DP, Latham ID, Chase JM, Fisher EM, Bouzyk MM, Potter A, Masih M, Walsh FS, Sims MA, Doncaster KE, Parsons CA, Martin J, Brown SD, Rastan S, Spurr NK, Gray IC.
Hum Mol Genet. 9(12):1865-71. 2000
24HNPP, PMP22
DNA rearrangements on both homologues of chromosome 17 in a mildly delayed individual with a family history of autosomal dominant carpal tunnel syndrome.
Potocki L, et al.
Am J Hum Genet 64(2):471-8. 1999
25CMT1A, PMP22
Effects of PMP22 duplication and deletions on the axonal cytoskeleton.
Sahenk Z, et al.
Ann Neurol 45(1):16-24. 1999
26PMP22, CMT1A
A unique point mutation in the PMP22 gene is associated with charcot-marie-tooth disease and deafness.
Kovach MJ, et al.
Am J Hum Genet 64(6):1580-93. 1999
27PMP22, MPZ
Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin.
D'Urso D, et al.
J Neurosci 19(9):3396-403. 1999
28CMT1A, HNPP, PMP22
Homologous DNA exchanges in humans can be explained by the yeast double-strand break repair model: a study of 17p11.2 rearrangements associated with CMT1A and HNPP.
Lopes J, et al.
Hum Mol Genet 8(12):2285-2292 1999
29CMT1A, PMP22
Myelin uncompaction in Charcot-Marie-Tooth neuropathy type 1A with a point mutation of peripheral myelin protein-22.
Fabrizi GM, Cavallaro T, Taioli F, Orrico D, Morbin M, Simonati A, Rizzuto N.
Neurology 53(4):846-51 1999
30CMT1A, DSS1, PMP22
Recessive inheritance of a new point mutation of the PMP22 gene in Dejerine-Sottas disease.
Parman Y, Plante-Bordeneuve V, Guiochon-Mantel A, Eraksoy M, Said G.
Ann Neurol 45(4):518-22. 1999
31CMT1A, PMP22
Novel mutations of the peripheral myelin protein 22 gene in two pedigrees with Dejerine-Sottas disease.
Ikegami T, et al.
Hum Genet 102 : 294-298. 1998
32HNPP, PMP22
Recurrent brachial plexus palsies as the only clinical expression of hereditary neuropathy with liability to pressure palsies associated with a de novo deletion of the peripheral myelin protein-22 gene.
Stogbauer F, Young P, Kerschensteiner M, Ringelstein EB, Assmann G, Funke H.
Muscle Nerve 21 : 1199-1201. 1998
33PMP22, RLAD
Roussy-Levy syndrome is a phenotypic variant of Charcot-Marie-Tooth syndrome IA associated with a duplication on chromosome 17p11.2.
Auer-Grumbach M, Strasser-Fuchs S, Wagner K, Korner E, Fazekas F.
J Neurol Sci 154(1):72-5. 1998
34CMT1A, PMP22
Prevalence and parental origin of De novo 1.5-Mb duplication in Charcot-Marie-Tooth disease type 1A.
Bort S, et al.
Am J Hum Genet 60 : 230-233. 1997
35CMT1A, PMP22
Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene.
Ionasescu VV, et al.
Muscle Nerve 20 : 97-99. 1997
36CMT1A, CMT1AREPC, CMT1AREPT, PMP22
Detection of the CMT1A/HNPP recombination hotsport in unrelated patients of European descent.
Timmerman V, et al.
J Med Genet 34 : 43-49. 1997
37CMT1A, PMP22
Patients homozygous for the 17p11.2 duplication in Charcot-Marie-Tooth type 1A disease.
Leguern E, et al.
Ann Neurol 41 : 104-108. 1997
38CMT1A, HNPP, PMP22
Polymorphisms in the PMP-22 gene region (17p11.2-12) are crucial for simplified diagnosis of duplications/deletions.
Haupt A, Schols L, Przuntek H, Epplen JT.
Hum Genet 99(5):688-91. 1997
39CMT1A, PMP22
Facilitated diagnosis of CMT1A duplication in chromosome 17p11.2-12: analysis with a CMT1A-REP repeat probe and photostimulated luminescence imaging.
Ikegami T, Ikeda H, Chance PF, Kiyosawa H, Yamamoto M, Sobue G, Ohnishi A, Tachi N, Hayasaka K.
Hum Mutat 9(6):563-6. 1997
40CMT1A, HNPP, PMP22
The phenotypic manifestations of chromosome 17p11.2 duplication.
Thomas PK, et al.
Brain 120 : 465-478. 1997
41CMT1A, PMP22
Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type 1A neuropathy. (abstr)
Roa BB, et al.
Hum Genet 97(5):642-9. 1996
42PMP22, HNPP
Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP).
Timmerman V, et al.
Hum Genet 97 : 26-34. 1996
43CMT1A, PMP22
Prevalence and origin of De novo duplications in Charcot-Marie-Tooth disease type 1A : first report of a de novo duplication with a maternal origin.
Blair IP, et al.
Am J Hum Genet 58 : 472-476. 1996
44CMT1A, PMP22
A new point mutation affecting the fourth transmembrane domain of PMP22 results in severe, de novo Charcot-Marie-Tooth disease.
Navon R, et al.
Hum Genet 97 : 685-687. 1996
45CMT1A, PMP22
Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type-1A neuropathy.
Roa BB, et al.
Hum Genet 97 : 642-649. 1996
46CMT1A, HNPP, PMP22
Microsatellite mapping of the deletion in patients with hereditary neuropathy with liability to pressure palsies (HNPP) : new molecular tools for the study of the region 17p12-p11 and for diagnosis.
LeGuern E, et al.
Cytogenet Cell Genet 72 : 20-25. 1996
47CMT1A, PMP22
Mosaicism for the Charcot-Marie-Tooth disease type 1A duplication suggests somatic reversion.
Liehr T, et al.
Hum Genet 98 : 22-28. 1996
48CMT1A, HNPP, PMP22, CMT1E
Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies : a European collaborative study.
Nelis E, et al.
Eur J Hum Genet 4 : 25-33. 1996
49CMT1A, HNPP, PMP22
Peripheral myelin protein-22 gene deletion in two unrelated Japanese pedigrees with hereditary neuropathy with liability to pressure palsies.
Kaneko S, et al.
Muscle Nerve 19 : 675-676. 1996
50CMT1A, PMP22
Dejerine-Sottas disease with sensorineural hearing loss, nystagmus, and peripheral facial nerve weakness : De novo dominant point mutation of the PMP22 gene.
Ionasescu VV, et al.
J Med Genet 33 : 1048-1049. 1996
51CMT1A, PMP22
A 1.5-Mb cosmid contig of the CMT1A duplication/HNPP deletion critical region in 17p11.2-p12.
Murakami T, et al.
Genomics 34 : 128-133. 1996
52PMP22
A transgenic rat model of Charcot-Marie-Tooth disease.
Sereda M, Griffiths I, Pühlhofer A, Stewart H, Rossner MJ, Zimmerman F, Magyar JP, Schneider A, Hund E, Meinck HM, Suter U, Nave KA.
Neuron. 16(5):1049-60. 1996
53CMT1A, PMP22
DŽjŽrine-Sottas neuropathy is associated with a De novo PMP22 mutation.
Valentijn LJ, et al.
Hum Mutat 5 : 76-80. 1995
54HNPP, PMP22
Hereditary neuropathy with liability to pressure palsies and inherited brachial plexus neuropathy - two genetically distinct disorders.
Windebank AJ, et al.
Mayo Clin Proc 70 : 743-746. 1995
55CMT1A, HNPP, PMP22
Asian hereditary neuropathy patients with peripheral myelin protein-22 gene aneuploidy.
Ohnishi A, et al.
Am J Med Genet 59 : 51-58. 1995
56PMP22, HNPP
DNA analysis as a tool to confirm the diagnosis of asymptomatic hereditary neuropathy with liability to pressure palsies (HNPP) with further evidence for the occurrence of De novo mutations.
Gonnaud PM, et al.
Acta Neurol Scand 92 : 313-318. 1995
57CMT1A, HNPP, PMP22
Analysis of the CMT1A-REP repeat : mapping crossover breakpoints in CMT1A and HNPP.
Kiyosawa H, et al.
Hum Mol Genet 4 : 2327-2334. 1995
58PMP22
Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family.
Taylor V, et al.
J Biol Chem 270 : 28824-28833. 1995
59HNPP, PMP22
Deletion in chromosome 17p11.2 including the peripheral myelin protein-22 (PMP-22) gene in hereditary neuropathy with liability to pressure palsies.
Umehara F, et al.
J Neurol Sci 133 : 173-176. 1995
60HNPP, PMP22
A 1.5-Mb deletion in 17p11.2-p12 is frequently observed in Italian families with hereditary neuropathy with liability to pressure palsies.
Lorenzetti D, et al.
Am J Hum Genet 56 : 91-98. 1995
61HNPP, PMP22
Detection of deletion within 17p11.2 in 7 French families with hereditary neuropathy with liability to pressure palsies (HNPP).
Le Guern E, et al.
Cytogenet Cell Genet 65 : 261-264. 1994
62PMP22, CMT1A
Identification of a 5' splice site mutation in the PMP-22 gene in autosomal dominant Charcot-Marie-Tooth disease type 1.
Nelis E, et al.
Hum Mol Genet 3 : 515-516. 1994
63PMP22, HNPP
A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies.
Nicholson GA, et al.
Nat Genet 6 : 263-266. 1994
64HNPP, PMP22, CMT1A
Deletion in the CMT1A locus on chromosome 17p11.2 in hereditary neuropathy with liability to pressure palsies.
Verhalle D, et al.
Ann Neurol 35 : 704-708. 1994
65PMP22, HNPP
Prevalence of the 1.5-Mb 17p deletion in families with hereditary neuropathy with liability to pressure palsies.
Mariman ECM, et al.
Ann Neurol 36 : 650-655. 1994
66CMT1A, PMP22
Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene.
Roa BB, et al.
Nat Genet 5 : 269-273. 1993
67CMT1A, PMP22
Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene.
Roa BB, et al.
N Engl J Med 329 : 96-101. 1993
68HNPP, PMP22, CMT1A
DNA deletion associated with hereditary neuropathy with liability to pressure palsies.
Chance PF, et al.
Cell 72 : 143-151. 1993
69PMP22
Isolation and mapping to 17p12-13 of the human homologous of the murine growth arrest specific Gas-3 gene.
Martinotti A, et al.
Hum Mol Genet 1 : 331-334. 1992
70CMT1A, PMP22
The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication.
Timmerman V, et al.
Nat Genet 1 : 171-175. 1992
71CMT1A, PMP22
Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A.
Matsunami N, et al.
Nat Genet 1 : 176-179. 1992
72PMP22
Structural and functional characterization of mammalian PMP-22 genes involved in inherited peripheral neuropathies.
Suter U, et al.
Am J Hum Genet 51 : A136. 1992
73PMP22
Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13).
Snipes GJ, et al.
J Cell Biol 117 : 225-238. 1992
74CMT1A, PMP22
A yeast artificial chromosome contig spanning the Charcot-Marie-Tooth disease type 1A duplication region.
Nieuwenhuijsen BW, et al.
Hum Mol Genet 1 : 605-612. 1992
75CMT1A, PMP22
Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A.
Valentijn LJ, et al.
Nat Genet 2 : 288-291. 1992